Neoantigen Targeted Therapies Market to 2027 - Global Analysis and Forecasts By Therapy Type (Combination Therapy and Monotherapy); End User (Hospitals & Clinics, Medical Research Institutions and Other End Users) and Geography
Report Code: TIPRE00008685 No. of Pages: 150 Category: Pharmaceuticals Status: Upcoming
MARKET INTRODUCTION
Neoantigen targeted therapies are being used widely for the treatment of cancerous cells. Neoantigens are tumor-specific antigens which formed due to the instability of tumor cells. Neoantigens are highly immunogenic; hence they are not expressed in healthy tissues. The concept of using identified neoantigens as vaccines to efficiently stimulate patients' autoimmune system and generate anti-tumor response has gained recognition.
MARKET DYNAMICS
The neoantigen targeted therapies market is anticipated to grow in the forecast, owing to an increasing prevalence of cancer, coupled with the availability of different treatment options. Also, the rise in R&D expenditures made by the manufacturers for the introduction of new drugs is anticipated to offer significant growth opportunities in the market during the forecast period.
MARKET SCOPE
The "Neoantigen Targeted Therapies Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a particular focus on the global market trend analysis. The report aims to provide an overview of the neoantigen targeted therapies market with detailed market segmentation by therapy type, end user, and geography. The neoantigen targeted therapies market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading neoantigen targeted therapies market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The neoantigen targeted therapies market is segmented based on therapy type and end user. Based on the therapy type, the market is segmented as combination therapy and monotherapy. Based on end user, the market is classified as hospitals & clinics, medical research institutions, and other end users.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the neoantigen targeted therapies market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The neoantigen targeted therapies market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting neoantigen targeted therapies market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the neoantigen targeted therapies market in these regions.
The report covers key developments in the neoantigen targeted therapies market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from neoantigen targeted therapies market are anticipated to have lucrative growth opportunities in the future with the rising demand for neoantigen targeted therapies market in the global market. Below mentioned is the list of few companies engaged in the neoantigen targeted therapies market.
The report also includes the profiles of key neoantigen targeted therapies market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Achilles Therapeutics
- Advaxis, Inc.
- Frame Cancer Therapeutics
- Genocea Biosciences, Inc.
- Gradalis, Inc.
- Gritstone Oncology
- Immunicum AB
- Iovance Biotherapeutics, Inc.
- Medigene
- Neon Therapeutics
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Neoantigen targeted therapies are being used widely for the treatment of cancerous cells. Neoantigens are tumor-specific antigens which formed due to the instability of tumor cells. Neoantigens are highly immunogenic; hence they are not expressed in healthy tissues. The concept of using identified neoantigens as vaccines to efficiently stimulate patients' autoimmune system and generate anti-tumor response has gained recognition.
MARKET DYNAMICS
The neoantigen targeted therapies market is anticipated to grow in the forecast, owing to an increasing prevalence of cancer, coupled with the availability of different treatment options. Also, the rise in R&D expenditures made by the manufacturers for the introduction of new drugs is anticipated to offer significant growth opportunities in the market during the forecast period.
MARKET SCOPE
The "Neoantigen Targeted Therapies Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a particular focus on the global market trend analysis. The report aims to provide an overview of the neoantigen targeted therapies market with detailed market segmentation by therapy type, end user, and geography. The neoantigen targeted therapies market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading neoantigen targeted therapies market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The neoantigen targeted therapies market is segmented based on therapy type and end user. Based on the therapy type, the market is segmented as combination therapy and monotherapy. Based on end user, the market is classified as hospitals & clinics, medical research institutions, and other end users.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the neoantigen targeted therapies market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The neoantigen targeted therapies market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting neoantigen targeted therapies market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the neoantigen targeted therapies market in these regions.
The report covers key developments in the neoantigen targeted therapies market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from neoantigen targeted therapies market are anticipated to have lucrative growth opportunities in the future with the rising demand for neoantigen targeted therapies market in the global market. Below mentioned is the list of few companies engaged in the neoantigen targeted therapies market.
The report also includes the profiles of key neoantigen targeted therapies market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Achilles Therapeutics
- Advaxis, Inc.
- Frame Cancer Therapeutics
- Genocea Biosciences, Inc.
- Gradalis, Inc.
- Gritstone Oncology
- Immunicum AB
- Iovance Biotherapeutics, Inc.
- Medigene
- Neon Therapeutics
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Neoantigen Targeted Therapies Market - By Therapy Type
1.3.2 Neoantigen Targeted Therapies Market - By End User
1.3.3 Neoantigen Targeted Therapies Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. NEOANTIGEN TARGETED THERAPIES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. NEOANTIGEN TARGETED THERAPIES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. NEOANTIGEN TARGETED THERAPIES MARKET - GLOBAL MARKET ANALYSIS
6.1. NEOANTIGEN TARGETED THERAPIES - GLOBAL MARKET OVERVIEW
6.2. NEOANTIGEN TARGETED THERAPIES - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. NEOANTIGEN TARGETED THERAPIES MARKET - REVENUE AND FORECASTS TO 2027 - THERAPY TYPE
7.1. OVERVIEW
7.2. THERAPY TYPE MARKET FORECASTS AND ANALYSIS
7.3. COMBINATION THERAPY
7.3.1. Overview
7.3.2. Combination Therapy Market Forecast and Analysis
7.4. MONOTHERAPY
7.4.1. Overview
7.4.2. Monotherapy Market Forecast and Analysis
8. NEOANTIGEN TARGETED THERAPIES MARKET - REVENUE AND FORECASTS TO 2027 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS & CLINICS
8.3.1. Overview
8.3.2. Hospitals & Clinics Market Forecast and Analysis
8.4. MEDICAL RESEARCH INSTITUTIONS
8.4.1. Overview
8.4.2. Medical Research Institutions Market Forecast and Analysis
8.5. OTHER END USERS
8.5.1. Overview
8.5.2. Other End Users Market Forecast and Analysis
9. NEOANTIGEN TARGETED THERAPIES MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Neoantigen Targeted Therapies Market Overview
9.1.2 North America Neoantigen Targeted Therapies Market Forecasts and Analysis
9.1.3 North America Neoantigen Targeted Therapies Market Forecasts and Analysis - By Therapy Type
9.1.4 North America Neoantigen Targeted Therapies Market Forecasts and Analysis - By End User
9.1.5 North America Neoantigen Targeted Therapies Market Forecasts and Analysis - By Countries
9.1.5.1 United States Neoantigen Targeted Therapies Market
9.1.5.1.1 United States Neoantigen Targeted Therapies Market by Therapy Type
9.1.5.1.2 United States Neoantigen Targeted Therapies Market by End User
9.1.5.2 Canada Neoantigen Targeted Therapies Market
9.1.5.2.1 Canada Neoantigen Targeted Therapies Market by Therapy Type
9.1.5.2.2 Canada Neoantigen Targeted Therapies Market by End User
9.1.5.3 Mexico Neoantigen Targeted Therapies Market
9.1.5.3.1 Mexico Neoantigen Targeted Therapies Market by Therapy Type
9.1.5.3.2 Mexico Neoantigen Targeted Therapies Market by End User
9.2. EUROPE
9.2.1 Europe Neoantigen Targeted Therapies Market Overview
9.2.2 Europe Neoantigen Targeted Therapies Market Forecasts and Analysis
9.2.3 Europe Neoantigen Targeted Therapies Market Forecasts and Analysis - By Therapy Type
9.2.4 Europe Neoantigen Targeted Therapies Market Forecasts and Analysis - By End User
9.2.5 Europe Neoantigen Targeted Therapies Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Neoantigen Targeted Therapies Market
9.2.5.1.1 Germany Neoantigen Targeted Therapies Market by Therapy Type
9.2.5.1.2 Germany Neoantigen Targeted Therapies Market by End User
9.2.5.2 France Neoantigen Targeted Therapies Market
9.2.5.2.1 France Neoantigen Targeted Therapies Market by Therapy Type
9.2.5.2.2 France Neoantigen Targeted Therapies Market by End User
9.2.5.3 Italy Neoantigen Targeted Therapies Market
9.2.5.3.1 Italy Neoantigen Targeted Therapies Market by Therapy Type
9.2.5.3.2 Italy Neoantigen Targeted Therapies Market by End User
9.2.5.4 Spain Neoantigen Targeted Therapies Market
9.2.5.4.1 Spain Neoantigen Targeted Therapies Market by Therapy Type
9.2.5.4.2 Spain Neoantigen Targeted Therapies Market by End User
9.2.5.5 United Kingdom Neoantigen Targeted Therapies Market
9.2.5.5.1 United Kingdom Neoantigen Targeted Therapies Market by Therapy Type
9.2.5.5.2 United Kingdom Neoantigen Targeted Therapies Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Neoantigen Targeted Therapies Market Overview
9.3.2 Asia-Pacific Neoantigen Targeted Therapies Market Forecasts and Analysis
9.3.3 Asia-Pacific Neoantigen Targeted Therapies Market Forecasts and Analysis - By Therapy Type
9.3.4 Asia-Pacific Neoantigen Targeted Therapies Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Neoantigen Targeted Therapies Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Neoantigen Targeted Therapies Market
9.3.5.1.1 Australia Neoantigen Targeted Therapies Market by Therapy Type
9.3.5.1.2 Australia Neoantigen Targeted Therapies Market by End User
9.3.5.2 China Neoantigen Targeted Therapies Market
9.3.5.2.1 China Neoantigen Targeted Therapies Market by Therapy Type
9.3.5.2.2 China Neoantigen Targeted Therapies Market by End User
9.3.5.3 India Neoantigen Targeted Therapies Market
9.3.5.3.1 India Neoantigen Targeted Therapies Market by Therapy Type
9.3.5.3.2 India Neoantigen Targeted Therapies Market by End User
9.3.5.4 Japan Neoantigen Targeted Therapies Market
9.3.5.4.1 Japan Neoantigen Targeted Therapies Market by Therapy Type
9.3.5.4.2 Japan Neoantigen Targeted Therapies Market by End User
9.3.5.5 South Korea Neoantigen Targeted Therapies Market
9.3.5.5.1 South Korea Neoantigen Targeted Therapies Market by Therapy Type
9.3.5.5.2 South Korea Neoantigen Targeted Therapies Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Neoantigen Targeted Therapies Market Overview
9.4.2 Middle East and Africa Neoantigen Targeted Therapies Market Forecasts and Analysis
9.4.3 Middle East and Africa Neoantigen Targeted Therapies Market Forecasts and Analysis - By Therapy Type
9.4.4 Middle East and Africa Neoantigen Targeted Therapies Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Neoantigen Targeted Therapies Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Neoantigen Targeted Therapies Market
9.4.5.1.1 South Africa Neoantigen Targeted Therapies Market by Therapy Type
9.4.5.1.2 South Africa Neoantigen Targeted Therapies Market by End User
9.4.5.2 Saudi Arabia Neoantigen Targeted Therapies Market
9.4.5.2.1 Saudi Arabia Neoantigen Targeted Therapies Market by Therapy Type
9.4.5.2.2 Saudi Arabia Neoantigen Targeted Therapies Market by End User
9.4.5.3 U.A.E Neoantigen Targeted Therapies Market
9.4.5.3.1 U.A.E Neoantigen Targeted Therapies Market by Therapy Type
9.4.5.3.2 U.A.E Neoantigen Targeted Therapies Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Neoantigen Targeted Therapies Market Overview
9.5.2 South and Central America Neoantigen Targeted Therapies Market Forecasts and Analysis
9.5.3 South and Central America Neoantigen Targeted Therapies Market Forecasts and Analysis - By Therapy Type
9.5.4 South and Central America Neoantigen Targeted Therapies Market Forecasts and Analysis - By End User
9.5.5 South and Central America Neoantigen Targeted Therapies Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Neoantigen Targeted Therapies Market
9.5.5.1.1 Brazil Neoantigen Targeted Therapies Market by Therapy Type
9.5.5.1.2 Brazil Neoantigen Targeted Therapies Market by End User
9.5.5.2 Argentina Neoantigen Targeted Therapies Market
9.5.5.2.1 Argentina Neoantigen Targeted Therapies Market by Therapy Type
9.5.5.2.2 Argentina Neoantigen Targeted Therapies Market by End User
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. NEOANTIGEN TARGETED THERAPIES MARKET, KEY COMPANY PROFILES
11.1. ACHILLES THERAPEUTICS
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. ADVAXIS, INC.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. FRAME CANCER THERAPEUTICS
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. GENOCEA BIOSCIENCES, INC.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. GRADALIS, INC.
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. GRITSTONE ONCOLOGY
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. IMMUNICUM AB
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. IOVANCE BIOTHERAPEUTICS, INC.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. MEDIGENE
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. NEON THERAPEUTICS
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Neoantigen Targeted Therapies Market - By Therapy Type
1.3.2 Neoantigen Targeted Therapies Market - By End User
1.3.3 Neoantigen Targeted Therapies Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. NEOANTIGEN TARGETED THERAPIES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. NEOANTIGEN TARGETED THERAPIES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. NEOANTIGEN TARGETED THERAPIES MARKET - GLOBAL MARKET ANALYSIS
6.1. NEOANTIGEN TARGETED THERAPIES - GLOBAL MARKET OVERVIEW
6.2. NEOANTIGEN TARGETED THERAPIES - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. NEOANTIGEN TARGETED THERAPIES MARKET - REVENUE AND FORECASTS TO 2027 - THERAPY TYPE
7.1. OVERVIEW
7.2. THERAPY TYPE MARKET FORECASTS AND ANALYSIS
7.3. COMBINATION THERAPY
7.3.1. Overview
7.3.2. Combination Therapy Market Forecast and Analysis
7.4. MONOTHERAPY
7.4.1. Overview
7.4.2. Monotherapy Market Forecast and Analysis
8. NEOANTIGEN TARGETED THERAPIES MARKET - REVENUE AND FORECASTS TO 2027 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS & CLINICS
8.3.1. Overview
8.3.2. Hospitals & Clinics Market Forecast and Analysis
8.4. MEDICAL RESEARCH INSTITUTIONS
8.4.1. Overview
8.4.2. Medical Research Institutions Market Forecast and Analysis
8.5. OTHER END USERS
8.5.1. Overview
8.5.2. Other End Users Market Forecast and Analysis
9. NEOANTIGEN TARGETED THERAPIES MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Neoantigen Targeted Therapies Market Overview
9.1.2 North America Neoantigen Targeted Therapies Market Forecasts and Analysis
9.1.3 North America Neoantigen Targeted Therapies Market Forecasts and Analysis - By Therapy Type
9.1.4 North America Neoantigen Targeted Therapies Market Forecasts and Analysis - By End User
9.1.5 North America Neoantigen Targeted Therapies Market Forecasts and Analysis - By Countries
9.1.5.1 United States Neoantigen Targeted Therapies Market
9.1.5.1.1 United States Neoantigen Targeted Therapies Market by Therapy Type
9.1.5.1.2 United States Neoantigen Targeted Therapies Market by End User
9.1.5.2 Canada Neoantigen Targeted Therapies Market
9.1.5.2.1 Canada Neoantigen Targeted Therapies Market by Therapy Type
9.1.5.2.2 Canada Neoantigen Targeted Therapies Market by End User
9.1.5.3 Mexico Neoantigen Targeted Therapies Market
9.1.5.3.1 Mexico Neoantigen Targeted Therapies Market by Therapy Type
9.1.5.3.2 Mexico Neoantigen Targeted Therapies Market by End User
9.2. EUROPE
9.2.1 Europe Neoantigen Targeted Therapies Market Overview
9.2.2 Europe Neoantigen Targeted Therapies Market Forecasts and Analysis
9.2.3 Europe Neoantigen Targeted Therapies Market Forecasts and Analysis - By Therapy Type
9.2.4 Europe Neoantigen Targeted Therapies Market Forecasts and Analysis - By End User
9.2.5 Europe Neoantigen Targeted Therapies Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Neoantigen Targeted Therapies Market
9.2.5.1.1 Germany Neoantigen Targeted Therapies Market by Therapy Type
9.2.5.1.2 Germany Neoantigen Targeted Therapies Market by End User
9.2.5.2 France Neoantigen Targeted Therapies Market
9.2.5.2.1 France Neoantigen Targeted Therapies Market by Therapy Type
9.2.5.2.2 France Neoantigen Targeted Therapies Market by End User
9.2.5.3 Italy Neoantigen Targeted Therapies Market
9.2.5.3.1 Italy Neoantigen Targeted Therapies Market by Therapy Type
9.2.5.3.2 Italy Neoantigen Targeted Therapies Market by End User
9.2.5.4 Spain Neoantigen Targeted Therapies Market
9.2.5.4.1 Spain Neoantigen Targeted Therapies Market by Therapy Type
9.2.5.4.2 Spain Neoantigen Targeted Therapies Market by End User
9.2.5.5 United Kingdom Neoantigen Targeted Therapies Market
9.2.5.5.1 United Kingdom Neoantigen Targeted Therapies Market by Therapy Type
9.2.5.5.2 United Kingdom Neoantigen Targeted Therapies Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Neoantigen Targeted Therapies Market Overview
9.3.2 Asia-Pacific Neoantigen Targeted Therapies Market Forecasts and Analysis
9.3.3 Asia-Pacific Neoantigen Targeted Therapies Market Forecasts and Analysis - By Therapy Type
9.3.4 Asia-Pacific Neoantigen Targeted Therapies Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Neoantigen Targeted Therapies Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Neoantigen Targeted Therapies Market
9.3.5.1.1 Australia Neoantigen Targeted Therapies Market by Therapy Type
9.3.5.1.2 Australia Neoantigen Targeted Therapies Market by End User
9.3.5.2 China Neoantigen Targeted Therapies Market
9.3.5.2.1 China Neoantigen Targeted Therapies Market by Therapy Type
9.3.5.2.2 China Neoantigen Targeted Therapies Market by End User
9.3.5.3 India Neoantigen Targeted Therapies Market
9.3.5.3.1 India Neoantigen Targeted Therapies Market by Therapy Type
9.3.5.3.2 India Neoantigen Targeted Therapies Market by End User
9.3.5.4 Japan Neoantigen Targeted Therapies Market
9.3.5.4.1 Japan Neoantigen Targeted Therapies Market by Therapy Type
9.3.5.4.2 Japan Neoantigen Targeted Therapies Market by End User
9.3.5.5 South Korea Neoantigen Targeted Therapies Market
9.3.5.5.1 South Korea Neoantigen Targeted Therapies Market by Therapy Type
9.3.5.5.2 South Korea Neoantigen Targeted Therapies Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Neoantigen Targeted Therapies Market Overview
9.4.2 Middle East and Africa Neoantigen Targeted Therapies Market Forecasts and Analysis
9.4.3 Middle East and Africa Neoantigen Targeted Therapies Market Forecasts and Analysis - By Therapy Type
9.4.4 Middle East and Africa Neoantigen Targeted Therapies Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Neoantigen Targeted Therapies Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Neoantigen Targeted Therapies Market
9.4.5.1.1 South Africa Neoantigen Targeted Therapies Market by Therapy Type
9.4.5.1.2 South Africa Neoantigen Targeted Therapies Market by End User
9.4.5.2 Saudi Arabia Neoantigen Targeted Therapies Market
9.4.5.2.1 Saudi Arabia Neoantigen Targeted Therapies Market by Therapy Type
9.4.5.2.2 Saudi Arabia Neoantigen Targeted Therapies Market by End User
9.4.5.3 U.A.E Neoantigen Targeted Therapies Market
9.4.5.3.1 U.A.E Neoantigen Targeted Therapies Market by Therapy Type
9.4.5.3.2 U.A.E Neoantigen Targeted Therapies Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Neoantigen Targeted Therapies Market Overview
9.5.2 South and Central America Neoantigen Targeted Therapies Market Forecasts and Analysis
9.5.3 South and Central America Neoantigen Targeted Therapies Market Forecasts and Analysis - By Therapy Type
9.5.4 South and Central America Neoantigen Targeted Therapies Market Forecasts and Analysis - By End User
9.5.5 South and Central America Neoantigen Targeted Therapies Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Neoantigen Targeted Therapies Market
9.5.5.1.1 Brazil Neoantigen Targeted Therapies Market by Therapy Type
9.5.5.1.2 Brazil Neoantigen Targeted Therapies Market by End User
9.5.5.2 Argentina Neoantigen Targeted Therapies Market
9.5.5.2.1 Argentina Neoantigen Targeted Therapies Market by Therapy Type
9.5.5.2.2 Argentina Neoantigen Targeted Therapies Market by End User
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. NEOANTIGEN TARGETED THERAPIES MARKET, KEY COMPANY PROFILES
11.1. ACHILLES THERAPEUTICS
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. ADVAXIS, INC.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. FRAME CANCER THERAPEUTICS
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. GENOCEA BIOSCIENCES, INC.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. GRADALIS, INC.
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. GRITSTONE ONCOLOGY
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. IMMUNICUM AB
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. IOVANCE BIOTHERAPEUTICS, INC.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. MEDIGENE
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. NEON THERAPEUTICS
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies
1. Achilles Therapeutics
2. Advaxis, Inc.
3. Frame Cancer Therapeutics
4. Genocea Biosciences, Inc.
5. Gradalis, Inc.
6. Gritstone Oncology
7. Immunicum AB
8. Iovance Biotherapeutics, Inc.
9. Medigene
10. Neon Therapeutics
1. Achilles Therapeutics
2. Advaxis, Inc.
3. Frame Cancer Therapeutics
4. Genocea Biosciences, Inc.
5. Gradalis, Inc.
6. Gritstone Oncology
7. Immunicum AB
8. Iovance Biotherapeutics, Inc.
9. Medigene
10. Neon Therapeutics